RECTAL INDOMETHACIN DECREASES POST-ERCP PANCREATITIS IN ELDERLY PATIENTS WITHOUT INCREASING THE RISK OF ACUTE KIDNEY INJURY

Authors

Do Han Kim MD, Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Donghyun Ko MD, Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, CT, USA.Follow
Jose A. Porres, Universidad Francisco Marroquin, Guatemala City, Guatemala.
Wilhelm S. Basegoda MD, University of South Alabama, Mobile, AL, USA
Carlos Eilzondo-Alatorre MD, Department of Medicine, NYC Health + Hospitals/Metropolitan, New York, NY, USA
Luis M. Nieto MD, Division of Gastroenterology and Hepatology, Emory University, Atlanta, GA, USA.
Miguel Salazar MD, Division of Gastroenterology and Hepatology, University of California Riverside, Rancho Cucamonga, CA
Paul T. Kroner MD, Department of Gastroenterology, Riverside Health System, Newport News, VA, USA.
Pedro Palacios Argueta MD, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
Frank J. Lukens MD, Division of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, FL, USA

Document Type

Conference Proceeding

Abstract

This study examines the association of use of rectal indomethacin with clinical outcomes in elderly patients undergoing ERCP using a large population-based multinational database.

Publication Date

5-2025

Recommended Citation

Kim, Do Han MD; Ko, Donghyun MD; Porres, Jose A.; Basegoda, Wilhelm S. MD; Eilzondo-Alatorre, Carlos MD; Nieto, Luis M. MD; Salazar, Miguel MD; Kroner, Paul T. MD; Palacios Argueta, Pedro MD; and Lukens, Frank J. MD, "RECTAL INDOMETHACIN DECREASES POST-ERCP PANCREATITIS IN ELDERLY PATIENTS WITHOUT INCREASING THE RISK OF ACUTE KIDNEY INJURY" (2025). Posters. 86.
https://scholar.bridgeporthospital.org/poster_presentations/86